Synosis Therapeutics
Latest round
- Series C
Last raised
- Oct 2010
Total raised
- $82M
Investors
- 8
About Synosis Therapeutics
Synosis Therapeutics Inc.Synosis Therapeutics Inc. specializes in developing treatments for neurological and psychiatric disorders. The company is headquartered in Basel, Switzerland. Founded by a team of experienced professionals in the biopharmaceutical industry, Synosis has undergone strategic pivots to focus on drug discovery. The most recent significant event was the acquisition by Biotie Therapies Corp.5 mn, marking a pivotal change in its operational direction.com primarily focuses on offering premium domain names and associated branding services tailored for startups and established businesses seeking a distinctive online presence.xyz. In addition to domain sales, Synosia provides a suite of services aimed at enhancing brand identity, including naming contests that connect businesses with experts who generate unique name ideas, logo design services facilitated by AI technology, and trademark validation and filing assistance. Their clientele spans various industries, including technology, design, and fashion, and the products are marketed primarily to global audiences, with particular emphasis on regions such as North America, Europe, and Asia-Pacific.Synosia's revenue model is structured around direct transactions for domain name purchases and associated services, including branding and trademark assistance.com. In addition to direct sales, the company may generate revenue through managed naming contests and logo design services, which facilitate collaborations between clients and creative professionals. The transactional structure is primarily B2B, serving a diverse client base that includes tech startups, design agencies, and other creative ventures. By offering payment plans for domain acquisitions, Synosia enables clients to manage their costs effectively while providing access to high-value assets upfront.Synosia Therapeutics Inc. is exploring the development of new therapies targeting specific neurological disorders, with potential product launches anticipated in the coming years. The company plans to expand its reach into emerging markets in Asia-Pacific and Latin America by 2025. will be utilized to support these initiatives and enhance research capabilities, facilitating the advancement of their drug candidates and speeding up the delivery of innovative solutions to patients.
Who invested in Synosis Therapeutics
8 investors across 4 rounds
See all investors in Synosis Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Synosis Therapeutics
Who invested in Synosis Therapeutics?
Synosis Therapeutics has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Synosis Therapeutics raised?
Synosis Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Synosis Therapeutics last raise money?
Synosis Therapeutics's most recent round on record is a Series C, in Oct 2010.
What does Synosis Therapeutics do?
Synosis Therapeutics is a biotechnology company.
Where is Synosis Therapeutics headquartered?
Synosis Therapeutics is headquartered in Basel, Switzerland.
Which VCs invest in companies like Synosis Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Synosis Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Synosis Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.